Vicapsys Life Sciences, Inc. (VICP)
1.45
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Vicapsys Life Sciences Cash from Operations (TTM) : -0.1292M for March 31, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.1292M |
| March 31, 2025 | -0.1241M |
| December 31, 2024 | -0.1217M |
| September 30, 2024 | -0.0231M |
| June 30, 2024 | -0.1423M |
| March 31, 2024 | -0.3604M |
| December 31, 2023 | -0.3671M |
| September 30, 2023 | -0.3848M |
| June 30, 2023 | -0.2663M |
| March 31, 2023 | -0.1322M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.2382M |
| September 30, 2022 | -0.3643M |
| June 30, 2022 | -0.5033M |
| March 31, 2022 | -0.4891M |
| December 31, 2021 | -0.444M |
| September 30, 2021 | -0.3211M |
| June 30, 2021 | -0.1444M |
| March 31, 2021 | -0.1005M |
| December 31, 2020 | -0.2629M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |
| Sarepta Therapeutics, Inc. | 93.95M |
| Anixa Biosciences, Inc. | -7.117M |